CD8A and neoplasm: In IKE-treated TIPE2−/− LLC tumor-bearing mice, increasing the accumulation of immunostimulatory MDSCs can promote effector CD4+ and CD8+ T cells, not immunosuppressive Tregs, to infiltrate into the tumor tissues.